National cancer Institute. The last years have seen an explosion of research and clinical trials testing new radiopharmaceuticals suggesting that targeting radiation therapy at the cellular level has the potential to reduce the risk of side effects while at the same time enabling even tiny deposits of cancer cells to be killed throughout the body. Read more >>